Reddit: https://old.reddit.com/r/worldnews/comments/asw5xt/historian_who_confronted_davos_billionaires_leaks/
Thursday, February 21, 2019
Wednesday, February 20, 2019
Goldman Sachs on Biotech: Is Curing Patients A Sustainable Business Model?
"Is curing patients a sustainable business model?" analysts ask in an April 10, 2018 report entitled "The Genome Revolution."
"The potential to deliver 'one shot cures' is one of the most attractive aspects of gene therapy, genetically-engineered cell therapy and gene editing. However, such treatments offer a very different outlook with regard to recurring revenue versus chronic therapies," analyst Salveen Richter wrote in the note to clients Tuesday. "While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow."
Labels:
money
Tuesday, February 19, 2019
Subscribe to:
Posts (Atom)